首站-论文投稿智能助手
典型文献
Atractylenolide-Ⅰ covalently binds to CYP11B2,selectively inhibits aldosterone synthesis,and improves hyperaldosteronism
文献摘要:
Hyperaldosteronism is a common disease that is closely related to endocrine hypertension and other cardiovascular diseases.Cytochrome P450 11B2(CYP11B2),an important enzyme in aldoste-rone(ALD)synthesis,is a promising target for the treatment of hyperaldosteronism.However,selective inhibitors targeting CYP11B2 are still lacking due to the high similarity with CYP11B1.In this study,atractylenolide-Ⅰ(AT-Ⅰ)was found to significantly reduce the production of ALD but had no effect on cortisol synthesis,which is catalyzed by CYP11B1.Chemical biology studies revealed that due to the presence of Ala320,AT-Ⅰ is selectively bound to the catalytic pocket of CYP11B2,and the C8/C9 double bond of AT-Ⅰ can be epoxidized,which then undergoes nucleophilic addition with the sulfhydryl group of Cys450 in CYP11B2.The covalent binding of AT-Ⅰ disrupts the interaction between heme and CYP11B2 and inactivates CYP11B2,leading to the suppression of ALD synthesis;AT-Ⅰ shows a significant thera-peutic effect for improving hyperaldosteronism.
文献关键词:
作者姓名:
Wenjuan Liu;Zhenqiang Li;Simeng Chu;Xiaoyao Ma;Xiaoying Wang;Min Jiang;Gang Bai
作者机构:
State Key Laboratory of Medicinal Chemical Biology,College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research,Nankai University,Tianjin 300353,China;Tianjin University of Traditional Chinese Medicine,Tianjin 300193,China
引用格式:
[1]Wenjuan Liu;Zhenqiang Li;Simeng Chu;Xiaoyao Ma;Xiaoying Wang;Min Jiang;Gang Bai-.Atractylenolide-Ⅰ covalently binds to CYP11B2,selectively inhibits aldosterone synthesis,and improves hyperaldosteronism)[J].药学学报(英文版),2022(01):135-148
A类:
Atractylenolide,Hyperaldosteronism,11B2,aldoste,rone,atractylenolide,Ala320,epoxidized,Cys450
B类:
covalently,binds,CYP11B2,selectively,inhibits,aldosterone,synthesis,improves,hyperaldosteronism,common,that,closely,related,endocrine,hypertension,other,cardiovascular,diseases,Cytochrome,P450,important,enzyme,ALD,promising,treatment,However,inhibitors,targeting,are,still,lacking,due,high,similarity,CYP11B1,In,this,study,AT,was,found,significantly,reduce,production,but,had,effect,cortisol,which,catalyzed,by,Chemical,biology,studies,revealed,presence,bound,catalytic,pocket,C8,C9,double,bond,then,undergoes,nucleophilic,addition,sulfhydryl,group,binding,disrupts,interaction,between,heme,inactivates,leading,suppression,shows,thera,peutic,improving
AB值:
0.529932
相似文献
Natural product 1,2,3,4,6-penta-O-galloyl-β-D-glucopyranose is a reversible inhibitor of glyceraldehyde 3-phosphate dehydrogenase
Wen Li;Li-ping Liao;Ning Song;Yan-jun Liu;Yi-luan Ding;Yuan-yuan Zhang;Xiao-ru Zhou;Zhong-ya Sun;Sen-hao Xiao;Hong-bo Wang;Jing Lu;Nai-xia Zhang;Hua-liang Jiang;Kai-xian Chen;Chuan-peng Liu;Jie Zheng;Ke-hao Zhao;Cheng Luo-School of Pharmacy,Key Laboratory of Molecular Pharmacology and Drug Evaluation(Yantai University),Ministry of Education,Collaborative Innovation Center of Advanced Drug Delivery System and Biotech Drugs in Universities of Shandong,Yantai University,Yantai 264005,China;Drug Discovery and Design Center,the Center for Chemical Biology,State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;University of Chinese Academy of Sciences,Beijing 100049,China;Center of Immunological Diseases,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;Department of Gastroenterology,Xinhua Hospital,School of Medicine,Shanghai Jiaotong University,Shanghai 201210,China;Department of Analytical Chemistry,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;School of Life Science and Technology,Shanghai Tech University,Shanghai 201210,China;School of Life Science and Technology,Harbin Institute of Technology,Harbin 200092,China;Department of Pharmacology,College of Pharmacy,Fujian Medical University,Fuzhou 350108,China
Discovery of SARS-CoV-2-E channel inhibitors as antiviral candidates
Yi Wang;Sui Fang;Yan Wu;Xi Cheng;Lei-ke Zhang;Xu-rui Shen;Shuang-qu Li;Jian-rong Xu;Wei-juan Shang;Zhao-bing Gao;Bing-qing Xia-CAS Key Laboratory of Receptor Research,Stake Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;University of Chinese Academy of Sciences,Beijing 100049,China;State Key Laboratory of Virology,Wuhan Institute of Virology,Center for Biosafety Mega-Science,Chinese Academy of Sciences,Wuhan 430071,China;Academy of Integrative Medicine,Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;Department of Pharmacology and Chemical Biology,Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China;Zhongshan Institute of Drug Discovery,Institution for Drug Discovery Innovation,Chinese Academy of Science,Zhongshan 528400,China
Okicamelliaside targets the N-terminal chaperone pocket of HSP90 disrupts the chaperone protein interaction of HSP90-CDC37 and exerts antitumor activity
Chuan-jing Cheng;Kai-xin Liu;Man Zhang;Fu-kui Shen;Li-li Ye;Wen-bo Wu;Xiao-tao Hou;Er-wei Hao;Yuan-yuan Hou;Gang Bai-State Key Laboratory of Medicinal Chemical Biology,College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research,Nankai University,Tianjin 300353,China;Collaborative Innovation Center of Research on Functional Ingredients from Agricultural Residues,Guangxi Key Laboratory of Efficacy Study on Chinese Materia Medica,Guangxi University of Chinese medicine,Nanning 530200,China;China-ASEAN Joint Laboratory for International Cooperation in Traditional Medicine Research,Guangxi University of Chinese Medicine,Nanning 530200,China
NFAT inhibitor 11R-VIVIT ameliorates mouse renal fibrosis after ischemia-reperfusion-induced acute kidney injury
Zhi-yong Xie;Wei Dong;Li Zhang;Meng-jie Wang;Zhen-meng Xiao;Yu-hua Zhang;Wan-xin Shi;Ying Huang;Yan Yang;Cui-li Li;Lei Fu;Xing-chen Zhao;Rui-zhao Li;Zhi-lian Li;Yuan-han Chen;Zhi-ming Ye;Shuang-xin Liu;Zheng Dong;Xin-ling Liang-The Second School of Clinical Medicine,Southern Medical University,Guangzhou 510515,China;Division of Nephrology,Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences,Guangzhou 510080,China;School of Medicine,South China University of Technology,Guangzhou 510006,China;Department of Cellular Biology and Anatomy,Medical College of Georgia at Augusta University,Augusta,GA,USA;Department of Medical Research,Charlie Norwood Veterans Affairs Medical Center,Augusta,GA,USA
Silibinin relieves UVB-induced apoptosis of human skin cells by inhibiting the YAP-p73 pathway
Wei-wei Liu;Fang Wang;Can Li;Xiao-yu Song;Wuxiyar Otkur;Yu-ying Zhu;Toshihiko Hayashi;Kazunori Mizuno;Shunji Hattori;Hitomi Fujisaki;Takashi Ikejima-Wuya College of Innovation,Shenyang Pharmaceutical University,Shenyang 110016,China;CAS Key Laboratory of Separation Science for Analytical Chemistry,Dalian Institute of Chemical Physics,Chinese Academy of Sciences,Dalian 116023,China;Department of Chemistry and Life science,School of Advanced Engineering,Kogakuin University,2665-1,Nakanomachi,Hachioji,Tokyo 192-0015,Japan;Nippi Research Institute of Biomatrix,Toride,Ibaraki 302-0017,Japan;Key Laboratory of Computational Chemistry-Based Natural Antitumor Drug Research&Development,Shenyang 110016,China
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。